Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Aurora, CO, USA.
Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.
Thorac Surg Clin. 2022 Feb;32(1):51-55. doi: 10.1016/j.thorsurg.2021.09.001.
Since the initial report of long-term survival after lung transplantation (LT) in 1983, there has been remarkable progress in the field and LT is now the gold-standard therapy for patients with end-stage lung disease. It confers a significant survival advantage and improves the quality of life in patients who often have few other treatment options. However, LT remains a complex undertaking and establishing and maintaining an LT program is resource intensive with multiple potential barriers. In this article, we focus on disparities in LT and the potential solutions to improving access to LT.
自 1983 年首次报道肺移植（LT）后的长期生存以来，该领域取得了显著进展，LT 现已成为终末期肺病患者的金标准治疗方法。它为那些通常几乎没有其他治疗选择的患者带来了显著的生存优势，并改善了他们的生活质量。然而，LT 仍然是一项复杂的工作，建立和维持 LT 项目需要大量资源，并且存在多种潜在障碍。在本文中，我们重点关注 LT 中的差异以及改善 LT 机会的潜在解决方案。
